Pronóstico del mercado de diagnóstico de cáncer cerebral en América del Sur y Central hasta 2028: impacto de COVID-19 y análisis regional por tipo de diagnóstico (prueba de imágenes, punción lumbar, biopsia, pruebas moleculares y otros); Tipo de cáncer (neuroma acústico, astrocitoma, craneofaringiomas, ganglioneuromas, glioblastoma multiforme, meningiomas, ependimomas y otros); Usuario final (hospitales, clínicas especializadas, centros de cirugía ambulatoria y otros)

Introducción al mercado

Los cánceres de cerebro se producen debido al crecimiento extracelular de las células del cerebro que causan los tumores. El tumor incluye tumores cerebrales primarios y tumores cerebrales secundarios. Los tumores cerebrales primarios se forman en el cerebro y no se diseminan a otras partes del cuerpo, mientras que los tumores secundarios, también conocidos como metástasis, son aquellos cánceres que comenzaron en otra parte del cuerpo. Los tumores cerebrales se clasifican en 40 tipos principales que a su vez se clasifican en dos grupos principales: benignos, es decir, de crecimiento lento y que tienen menos posibilidades de propagarse, y malignos, es decir, cancerosos y con mayor probabilidad de propagarse.

< p>Por lo tanto, se espera que el aumento de la prevalencia del cáncer de cerebro cree una demanda significativa de diagnósticos de cáncer de cerebro en los próximos años, lo que se prevé que impulse aún más el mercado de diagnóstico de cáncer de cerebro.

¿El COVID? 19 es una prueba crítica para los sistemas de salud públicos de América del Sur y Central, ya sobrecargados y con fondos insuficientes. Sufre graves desigualdades. Con una vasta población que vive en la pobreza, América del Sur y Central enfrentan continuamente problemas de salud generalizados debido al hacinamiento, el saneamiento limitado, la inseguridad alimentaria y las condiciones ambientales impredecibles. Los hospitales estatales con fondos insuficientes son la única fuente de atención médica en la región. Brasil se encuentra en una situación crítica debido al COVID-1. La falta de recursos está creando más desafíos en la región, obstaculizando el crecimiento del mercado de diagnóstico del cáncer de cerebro. Todos estos factores restringirán la distribución y adopción de productos y servicios de diagnóstico que restringirán el crecimiento del mercado. Sin embargo, a medida que continúe la vacunación en estos países, los distintos actores del mercado en esta región comenzarán nuevamente a centrarse en el desarrollo de diagnósticos de cáncer de cerebro y aumentarán la distribución de sus productos. Por lo tanto, el impacto de la pandemia se moderará en el mercado de diagnóstico del cáncer de cerebro.

Descripción general y dinámica del mercado

Se espera que el mercado de diagnóstico de cáncer de cerebro en América del Sur y Central crezca de 69,7 millones de dólares en 2021 a 175,8 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 14,1% de 2021 a 2028. El término \"tumor cerebral primario\" se refiere a un tumor que comienza en el cerebro. El cáncer de cerebro y del sistema nervioso es la décima causa de mortalidad en hombres y mujeres. A lo largo de la vida de una persona, las posibilidades de tener este tipo de tumor son inferiores al 1%. La mayoría de las neoplasias malignas primarias del sistema nervioso central (SNC) son tumores cerebrales, que representan del 85% al 90% de todos los casos. Los tumores cerebrales pueden ser fatales, tener un impacto severo en la calidad de vida y, en última instancia, transformar la vida del paciente y su familia. Además, la detección temprana de tumores suele ofrecer más opciones de tratamiento. La tecnología de imágenes avanzada puede identificar la ubicación de los tumores cerebrales. Las herramientas de diagnóstico incluyen imágenes por resonancia magnética (MRI) y tomografía computarizada (CT o CAT). La resonancia magnética intraoperatoria también se puede utilizar para guiar la biopsia de tejido y la resección del tumor durante la cirugía. La espectroscopia de resonancia magnética (MRS) se utiliza para examinar las características químicas de los tumores. Por tanto, el aumento de la prevalencia del cáncer de cerebro exige en gran medida herramientas de diagnóstico del cáncer de cerebro.

Segmentos clave del mercado

En términos de tipo de diagnóstico, el segmento de pruebas de imágenes representó la mayor participación del mercado de diagnóstico de cáncer cerebral de América del Sur y Central en 2020. En términos de tipo de cáncer, el segmento de glioblastoma multiforme representó la mayor participación del mercado de diagnóstico de cáncer cerebral de América del Sur y Central. mercado de diagnóstico de cáncer en 2020. En términos de usuario final, el segmento de hospitales representó la mayor participación del mercado de diagnóstico de cáncer cerebral de América del Sur y Central en 2020.

Principales fuentes y empresas enumeradas

Algunas fuentes primarias y secundarias importantes a las que se hace referencia para preparar Este informe sobre el mercado de diagnóstico de cáncer de cerebro en América del Sur y Central son sitios web de empresas, informes anuales, informes financieros, documentos del gobierno nacional y bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. y Neusoft Medical Systems.

Razones Comprar informe

Comprender el panorama del mercado de diagnóstico de cáncer de cerebro de América del Sur y Central e identificar los segmentos del mercado que tienen más probabilidades de garantizar un fuerte retorno
Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de diagnóstico de cáncer cerebral de América del Sur y Central
Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el Sur y el mercado de diagnóstico de cáncer de cerebro de América Central al identificar los segmentos de mercado con las ventas probables más prometedoras
Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos del mercado de diagnóstico de cáncer de cerebro de América del Sur y Central.
Obtener una previsión de ingresos para el mercado por varios segmentos entre 2021 y 2028 en la región de América del Sur y Central.

Segmentación del mercado de diagnóstico de cáncer de cerebro en América del Sur y Central

Por tipo de diagnóstico

Prueba de imagen
- Resonancia magnética
- Tomografía computarizada
- PET
Biopsia
Pruebas moleculares
Punción lumbar
Otros

Por tipo de cáncer

< ul>

Glioblastoma multiforme

Astrocitomas

Ependimomas

Otros

Por Usuario final

Hospitales
Clínicas especializadas
Centros de Cirugía Ambulatoria
Otros

Por país

América del Sur y Central
- Brasil
- Argentina
- Resto de América del Sur y Central

Empresas mencionadas

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 South and Central America Brain Cancer Diagnostics Market – By Country

2. South and Central America Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South and Central America Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- South and Central America PEST Analysis

4.3 Expert Opinion

5. South and Central America Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Future Trends

5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4 Impact Analysis

6. Brain Cancer Diagnostics Market – South and Central America Analysis

6.1 South and Central America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 South and Central America: Brain Cancer Diagnostics Market

10.1.1 Overview

10.1.2 South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.2 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Brazil Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1.1 Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3 Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.3 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 Argentina Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3 Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.4 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3 Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.5 Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on South and Central America Brain Cancer Diagnostics Market

11.1 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Biocept, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Koninklijke Philips N.V.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Canon Medical Systems

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Hitachi, Ltd.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Neusoft Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Brazil Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 2. Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3. Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4. Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5. Argentina Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 6. Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 7. Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 9. Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11. Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments in the Brain Cancer Diagnostics Market

Table 14. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 15. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. South and Central America Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - South and Central America PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. South and Central America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. South and Central America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29. Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 30. Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 31. Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in South and Central American Country Markets

Figure 33. Growth Strategies Done by the Companies in the Market, (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America brain cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South and Central America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample